{"schema_version":"1","generated_at":"2026-11-01T23:20:57.681Z","data_as_of":null,"url":"https://www.findmykol.com/kol/cory-gamble","json_url":"https://www.findmykol.com/kol/cory-gamble/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"cory-gamble","name":"Cory Gamble","credential":"DO","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"Novo Nordisk","institution_url":"https://www.findmykol.com/institution/novo-nordisk","city":"Fort Smith","state":"AR","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1396763918","orcid":"0000-0001-9343-4761","openalex":"A5045136677"},"summary":"Cory Gamble is an Endocrinology/Metabolic physician affiliated with Novo Nordisk. OpenAlex indexes 29 publications with 429 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":29,"cited_by_count":429,"h_index":8,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Novo Nordisk Inc","program_year":2021,"amount_usd":111500,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1396763918"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1396763918","source":"payments"},"publications":{"total":19,"shown":5,"withheld":14,"matched_by":"OpenAlex author record","recent":[{"title":"Macrovascular and microvascular complications in <scp>US</scp> Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease","year":2025,"journal":"Diabetes Obesity and Metabolism","source_url":"https://doi.org/10.1111/dom.16441","status":"verified"},{"title":"Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease","year":2025,"journal":"Diabetes Research and Clinical Practice","source_url":"https://doi.org/10.1016/j.diabres.2025.112162","status":"verified"},{"title":"Once-Weekly Semaglutide Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (PAUSE)","year":2025,"journal":"Diabetes Therapy","source_url":"https://doi.org/10.1007/s13300-025-01721-y","status":"verified"},{"title":"Author response for \"Macrovascular and microvascular complications in &lt;scp&gt;US&lt;/scp&gt; Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease\"","year":2025,"source_url":"https://doi.org/10.1111/dom.16441/v2/response1","status":"verified"},{"title":"Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)","year":2024,"journal":"Clinical Drug Investigation","source_url":"https://doi.org/10.1007/s40261-024-01354-2","status":"verified"}],"source":"works"},"contact":{"address_1":"6801 ROGERS AVE","city":"Fort Smith","state":"AR","zip":"729034067","phone":"479-452-2077","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1396763918","source":"identity"},"similar":[{"name":"Nikolaus Marx","slug":"nikolaus-marx","institution":"Novo Nordisk","url":"https://www.findmykol.com/kol/nikolaus-marx","json_url":"https://www.findmykol.com/kol/nikolaus-marx/profile.json"},{"name":"G. Kees Hovingh","slug":"g-hovingh","institution":"Novo Nordisk","url":"https://www.findmykol.com/kol/g-hovingh","json_url":"https://www.findmykol.com/kol/g-hovingh/profile.json"},{"name":"Joanna M. M. Howson","slug":"joanna-howson","institution":"Novo Nordisk","url":"https://www.findmykol.com/kol/joanna-howson","json_url":"https://www.findmykol.com/kol/joanna-howson/profile.json"},{"name":"G. Kees Hovingh","slug":"g-hovingh-dk","institution":"Novo Nordisk","url":"https://www.findmykol.com/kol/g-hovingh-dk","json_url":"https://www.findmykol.com/kol/g-hovingh-dk/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":14}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-09-13","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}